NIOX Group Plc

LSE NIOX.L

NIOX Group Plc Operating Cash Flow for the year ending December 30, 2023: USD 14.76 M

NIOX Group Plc Operating Cash Flow is USD 14.76 M for the year ending December 30, 2023, a 82.27% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • NIOX Group Plc Operating Cash Flow for the year ending December 30, 2022 was USD 8.10 M, a 328.42% change year over year.
  • NIOX Group Plc Operating Cash Flow for the year ending December 30, 2021 was USD 1.89 M, a 105.80% change year over year.
  • NIOX Group Plc Operating Cash Flow for the year ending December 30, 2020 was USD -32.56 M, a 1.05% change year over year.
  • NIOX Group Plc Operating Cash Flow for the year ending December 30, 2019 was USD -32.91 M, a 36.14% change year over year.
Key data
Date Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid
Market news
LSE: NIOX.L

NIOX Group Plc

CEO Mr. Ian Roy Johnson
IPO Date March 13, 2014
Location United Kingdom
Headquarters Hayakawa Building
Employees 92
Sector Health Care
Industries
Pharmaceuticals Biotechnology Medical Instruments
Description

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

StockViz Staff

January 15, 2025

Any question? Send us an email